Cardax Overview

  • Founded
  • 2006
  • Status
  • Public
  • Employees
  • 12
  • Stock Symbol
  • CDXI
Stock Symbol
  • Share Price
  • $2.28
  • (As of Thursday Closing)

Cardax General Information


Cardax Inc is a life sciences company engaged in the development of marketing, and distribution of consumer health products in the United States. The firm's platform has application in arthritis, metabolic syndrome, liver disease, and cardiovascular disease, as well as macular degeneration and prostate disease. It is focused on the development of astaxanthin technologies. The group's product ZanthoSyn is marketed as a novel astaxanthin dietary supplement. Astaxanthin is a clinically studied ingredient with a safe anti-inflammatory activity that supports joint health, cardiovascular health, metabolic health, and liver health. Geographically, it generates maximum revenue from the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Drug Discovery
Other Industries
Stock Exchange
Primary Office
  • 2800 Woodlawn Drive
  • Suite 129
  • Honolulu, HI 96822
  • United States
+1 (808) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardax Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.28 $2.26 $2.00 - $50.00 $1.73M 759K 507.00 -$7.21

Cardax Financials Summary

In Thousands,
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 4,602 9,350 26,469 16,770
Revenue 778 711 1,511 610
EBITDA (3,538) (4,430) (3,991) (1,956)
Net Income (5,579) (5,093) (4,024) (1,985)
Total Assets 1,711 2,019 2,459 3,157
Total Debt 3,936 2,597 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cardax Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cardax‘s full profile, request access.

Request a free trial

Cardax Executive Team (5)

Name Title Board Seat Contact Info
David Watumull Co-Founder, Board Member, President & Chief Executive Officer
John Russell Chief Financial Officer, Finance & Treasurer, Finance
David Watumull Chief Operating Officer
To view Cardax’s complete executive team members history, request access »

Cardax Board Members (6)

Name Representing Role Since
00000 00000000 Cardax Co-Founder, Board Member, President & Chief Executive Officer 000 0000
000000 00000000000 000 Self Chairman & Board Member 000 0000
0000000 00000 00 Cardax Board Member 000 0000
0000000 00000 00.0 Self Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Cardax Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cardax Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cardax‘s full profile, request access.

Request a free trial